Inhibikase Therapeutics (IKT) Property, Plant & Equipment (Net) Growth (3y) (2025)

Inhibikase Therapeutics (IKT) Property, Plant & Equipment (Net) Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 14.05%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 11.65%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 411.50%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 16.78%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -56.31%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.66%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 19.96%
10 Inhibikase Therapeutics 420.72 Mn 261.70 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 -18.08%